Apollo Endosurgery Inc. (APEN)
NASDAQ: APEN
· Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM
Apollo Endosurgery Revenue Breakdown
| Period Ending | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|
| Other Products Revenue | 794K | 477K |
| Other Products Revenue Growth | +66.46% | n/a |
| Surgical Revenue | 27.59M | 32.48M |
| Surgical Revenue Growth | -15.06% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 13K | 33K | 82K | 3.71M | 7.91M | 31.86M | 27.11M |
| Non-Us Revenue Growth | -60.61% | -59.76% | -97.79% | -53.09% | -75.16% | +17.51% | n/a |
| United States Revenue | 735K | 894K | 1.45M | n/a | 10.79M | 32.45M | 37.76M |
| United States Revenue Growth | -17.79% | -38.47% | n/a | -100.00% | -66.74% | -14.05% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.2M | 13.78M | 14.17M | 13.45M | 11.86M | 10.7M | 11.34M | 8.86M | 7.77M | 6.55M | 4.42M | 9.67M | 10.1M | 9.65M | 11.15M | 11.41M | 11.6M | 10.37M | 11.74M | 12.56M | 11.51M | 10.84M | 11.86M | 12.57M | 18.08M | 1.52M | 1.73M | 963.51K | 935.72K | 858.01K | 1.1M | 1.05M |
| Selling, General, and Administrative Revenue Growth | +10.29% | -2.76% | +5.33% | +13.41% | +10.87% | -5.70% | +28.04% | +13.96% | +18.65% | +48.17% | -54.27% | -4.31% | +4.66% | -13.39% | -2.35% | -1.60% | +11.92% | -11.70% | -6.57% | +9.19% | +6.19% | -8.60% | -5.66% | -30.48% | +1087.67% | -12.25% | +80.03% | +2.97% | +9.06% | -22.12% | +4.85% | n/a |
| Research and Development Revenue | 3.48M | 2.8M | 2.92M | 2.71M | 2.48M | 2.57M | 2.55M | 1.93M | 2.19M | 1.52M | 1.81M | 2.15M | 2.14M | 2.13M | 2.69M | 3.43M | 2.9M | 3.67M | 3.15M | 2.46M | 1.88M | 2.18M | 2.29M | 1.96M | 5.34M | 538.08K | 935.62K | 991.91K | 1.41M | 1.43M | 2.92M | 2.76M |
| Research and Development Revenue Growth | +24.05% | -3.94% | +7.52% | +9.44% | -3.43% | +0.67% | +32.26% | -11.80% | +43.63% | -16.14% | -15.46% | +0.37% | +0.52% | -20.86% | -21.56% | +18.41% | -21.14% | +16.39% | +28.42% | +30.71% | -13.73% | -4.68% | +16.76% | -63.35% | +892.30% | -42.49% | -5.67% | -29.74% | -1.28% | -50.97% | +5.85% | n/a |
| Sales and Marketing Revenue | 10.08M | 8.58M | 9.13M | 8.22M | 7.39M | 6.12M | 6M | 4.79M | 4.58M | 4.18M | 2.27M | 6.33M | 6.74M | 6.5M | 7.8M | 7.7M | 7.75M | 7.34M | 8.49M | 9.24M | 8.08M | 7.98M | 8.61M | 8.38M | 8.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | +17.38% | -5.97% | +11.06% | +11.19% | +20.74% | +1.97% | +25.37% | +4.54% | +9.67% | +84.46% | -64.22% | -6.01% | +3.70% | -16.76% | +1.38% | -0.72% | +5.57% | -13.49% | -8.18% | +14.45% | +1.25% | -7.31% | +2.72% | +4.04% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |